Pediatric sublingual allergen immunotherapy

被引:5
|
作者
Blaiss, Michael S. [1 ]
机构
[1] Augusta Univ, Med Coll Georgia, Dept Pediat, Augusta, GA USA
关键词
MITE-SENSITIZED CHILDREN; DOUBLE-BLIND; ATOPIC-DERMATITIS; EAACI GUIDELINES; EFFICACY; SAFETY; RHINITIS; RHINOCONJUNCTIVITIS; ASTHMA;
D O I
10.2500/aap.2022.43.210079
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Sublingual immunotherapy (SLIT) offers an important therapeutic modality in the management of children with respiratory allergies. Along with subcutaneous immunotherapy, these modalities are the only selections that have shown not merely relief of symptoms but also disease-modifying activity. SLIT can be given as either a dissolvable tablet (SLIT-T) or liquid drops (SLIT-D). In studies that examined the efficacy and safety in allergic rhinitis and asthma, SLIT-T and SLIT-D both show efficacy in reducing symptoms and the need for medication, although it seems that SLIT-T may show a better response. Almost all SLIT-D efficacy studies are with single allergens. There are virtually no data on the efficacy of mixing unrelated allergens in the same prescription. Both SLIT-T and SLIT-D treatments are safe, with the most common adverse effects being local ones, such as oral pruritus and mouth irritation, which tend to be mild and short lived. Studies that assess the role of SLIT in the prevention of new sensitizations and asthma in the pediatric population are insufficient and of mixed results; therefore, no conclusions can be made. In the treatment of other pediatric conditions, such as food allergy and atopic dermatitis, there are few studies that assessed if, and the degree of, the benefit with SLIT. In determining if SLIT should be prescribed for the pediatric patient, there is a need for shared decision-making to allow the older child and parents or caregivers to understand the pros and cons, and the costs of all the options and relate their values and preferences to the physician.
引用
收藏
页码:281 / 285
页数:5
相关论文
共 50 条
  • [31] House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma
    Richards, Jessika R.
    Stumpf, Janice L.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (10) : 1019 - 1030
  • [32] The Future of Sublingual Immunotherapy in the United States
    Pleskovic, Nicole
    Bartholow, Ashton
    Gentile, Deborah A.
    Skoner, David P.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2015, 15 (08) : 1 - 9
  • [33] Will Sublingual Immunotherapy Offer Benefit for Asthma?
    Baena-Cagnani, Carlos E.
    Larenas-Linnemann, Desiree
    Teijeiro, Alvaro
    Canonica, Giorgio Walter
    Passalacqua, Giovanni
    CURRENT ALLERGY AND ASTHMA REPORTS, 2013, 13 (06) : 571 - 579
  • [34] Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units
    Larenas-Linnemann, Desiree
    Esch, Robert
    Plunkett, Greg
    Brown, Shannon
    Maddox, Daniel
    Barnes, Charles
    Constable, Derek
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : 448 - 458
  • [35] Quality of life outcomes with sublingual immunotherapy
    Wise, Sarah K.
    Woody, Jamie
    Koepp, Sarah
    Schlosser, Rodney J.
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2009, 30 (05) : 305 - 311
  • [36] Enhanced efficacy of sublingual immunotherapy by liposome-mediated delivery of allergen
    Aliu, Have
    Rask, Carola
    Brimnes, Jens
    Andresen, Thomas Lars
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2017, 12 : 8377 - 8388
  • [37] Allergen immunotherapy today - sublingual or subcutaneous?
    Eng, PA
    ALLERGOLOGIE, 2003, 26 (12) : 524 - 532
  • [38] Adult and pediatric clinical trials of sublingual immunotherapy in the USA
    Park, Dai
    Daher, Nora
    Blaiss, Michael S.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (06) : 557 - 564
  • [39] SAFETY OF SUBLINGUAL IMMUNOTHERAPY
    Ciprandi, G.
    Marseglia, G. L.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2011, 25 (01) : 1 - 6
  • [40] Sublingual allergen immunotherapy in Tunisia: Safety and efficacy profile
    Daboussi, S.
    Mhamdi, S.
    Aichaouia, C.
    Moetamri, Z.
    Mejri, I
    Khadraoui, M.
    Cheikh, R.
    REVUE FRANCAISE D ALLERGOLOGIE, 2018, 58 (04): : 299 - 303